Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.62
-4.34 (-1.79%)
AAPL  269.48
-0.53 (-0.20%)
AMD  242.11
-4.16 (-1.69%)
BAC  54.45
+0.42 (0.78%)
GOOG  340.70
-4.20 (-1.22%)
META  691.70
-14.71 (-2.08%)
MSFT  411.21
-12.16 (-2.87%)
NVDA  180.34
-5.27 (-2.84%)
ORCL  154.67
-5.39 (-3.37%)
TSLA  421.96
+0.15 (0.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.